Waters Corporation's stock soared 12.62% during Tuesday's intraday trading session following the release of its first-quarter fiscal 2026 financial results, which significantly exceeded analyst expectations.

The company reported adjusted earnings per share of $2.70, a 20% year-over-year increase that beat consensus estimates of approximately $2.34. Revenue surged to $1.27 billion, surpassing expectations of around $1.20 billion, driven by a $520 million contribution from the recently acquired Biosciences and Diagnostic Solutions unit and solid organic growth in its Analytical Sciences Division.

Furthermore, Waters raised its full-year 2026 outlook, increasing its organic constant currency revenue growth guidance to 6.5%-8.0% and lifting its adjusted EPS forecast to a range of $14.40 to $14.60. CEO Udit Batra cited improved growth rates in the biosciences and advanced diagnostics businesses and early revenue synergies from the acquisition as key drivers behind the strong performance and optimistic guidance.